Cargando…

COVID-19 Drug Development

Diagnostics, vaccines, and drugs are indispensable tools and control measures employed to overcome infectious diseases such as coronavirus disease 2019 (COVID-19). Diagnostic tools based on RT-PCR were developed early in the COVID-19 pandemic and were urgently required for quarantine (testing, traci...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kim, Seungtaek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Microbiology and Biotechnology 2022
Materias:	Mini-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628783/ https://www.ncbi.nlm.nih.gov/pubmed/34866128 http://dx.doi.org/10.4014/jmb.2110.10029

Ejemplares similares

Landscape and progress of global COVID-19 vaccine development
por: Huang, Hui-Yao, et al.
Publicado: (2021)

Detection technologies and recent developments in the diagnosis of COVID-19 infection
por: Rai, Praveen, et al.
Publicado: (2021)

COVID-19 vaccine development from the perspective of cancer patients
por: He, Yang, et al.
Publicado: (2021)

Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance
por: Choudhary, R., et al.
Publicado: (2020)

A Mini Review on Discovery and Synthesis of Remdesivir as an Effective and Promising Drug against COVID-19
por: Zarenezhad, E., et al.
Publicado: (2021)

Drug repurposing strategies in the development of potential antifungal agents
por: Zhang, Qian, et al.
Publicado: (2021)

NASH Drug Development: Seeing the Light at the End of the Tunnel?
por: Chen, Yong Q.
Publicado: (2023)

Targeting Some Enzymes with Repurposing Approved Pharmaceutical Drugs for Expeditious Antiviral Approaches Against Newer Strains of COVID-19
por: Mohanty, Swati Sucharita, et al.
Publicado: (2021)

Using the prone position could help to combat the development of fast hypoxia in some patients with COVID‐19
por: Lindahl, Sten G. E.
Publicado: (2020)

Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19
por: Santin, A.D., et al.
Publicado: (2021)

New Molecules in Babesia gibsoni and Their Application for Diagnosis, Vaccine Development, and Drug Discovery
por: Goo, Youn-Kyoung, et al.
Publicado: (2014)

Anti-cancer drug discovery and development: Bcl-2 family small molecule inhibitors
por: Liu, Qiang, et al.
Publicado: (2012)

Perspectives on the development of antibody-drug conjugates targeting ROR1 for hematological and solid cancers
por: Peng, Haiyong
Publicado: (2021)

COVID-19 Cliff Notes: A COVID-19 Multidisciplinary Care Compendium
por: Williams, Kirsten M., et al.
Publicado: (2021)

Antibody glycosylation in COVID-19
por: Pongracz, Tamas, et al.
Publicado: (2022)

The microbial coinfection in COVID-19
por: Chen, Xi, et al.
Publicado: (2020)

Recombinant vaccines for COVID-19
por: Yadav, Tushar, et al.
Publicado: (2020)

Glucagon‐like peptide‐1 receptor agonists for type 2 diabetes: A rational drug development
por: Ahrén, Bo
Publicado: (2018)

How the VALID Act could affect patient access to laboratory developed testing for therapeutic drug monitoring
por: Saitman, Alec
Publicado: (2023)

Drug metabolism and drug transport of the 100 most prescribed oral drugs
por: Iversen, Ditte B., et al.
Publicado: (2022)

Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVID
por: Narayanan, J., et al.
Publicado: (2023)

Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review
por: Yeo, Suji, et al.
Publicado: (2023)

Cancer and Covid-19: Collectively catastrophic
por: du Plessis, M., et al.
Publicado: (2022)

COVID-19: the current situation in Nepal
por: Panthee, B., et al.
Publicado: (2020)

Diagnosis of COVID-19: facts and challenges
por: Zalzala, H.H.
Publicado: (2020)

All about COVID-19 in brief
por: Naserghandi, A., et al.
Publicado: (2020)

Applications of nanomaterials in COVID-19 pandemic
por: Xiao, Mei-Fang, et al.
Publicado: (2021)

Nutrition and immunity: lessons for COVID-19
por: Calder, Philip C.
Publicado: (2021)

Nutrition and immunity: lessons for COVID-19
por: Calder, Philip C.
Publicado: (2021)

Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19
por: Karthik, Kumaragurubaran, et al.
Publicado: (2020)

Systems Modeling to Quantify Safety Risks in Early Drug Development: Using Bifurcation Analysis and Agent-Based Modeling as Examples
por: Pin, Carmen, et al.
Publicado: (2021)

Drug Interactions of Metformin Involving Drug Transporter Proteins
por: Pakkir Maideen, Naina Mohamed, et al.
Publicado: (2017)

Influence of COVID-19 vaccines on endocrine system
por: Zhao, Ying, et al.
Publicado: (2022)

The osteo-metabolic phenotype of COVID-19: an update
por: di Filippo, Luigi, et al.
Publicado: (2022)

Wearable respiratory sensors for COVID‐19 monitoring
por: Chen, Guorui, et al.
Publicado: (2022)

COVID-19: benefits and risks of passive immunotherapeutics
por: Gupta, Ankur, et al.
Publicado: (2020)

Recent advances in vaccine and immunotherapy for COVID-19
por: Rabaan, Ali A., et al.
Publicado: (2020)

Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes
por: Mauvais-Jarvis, Franck, et al.
Publicado: (2020)

COVID-19 outbreak: current scenario of Pakistan
por: Waris, A., et al.
Publicado: (2020)

Gastrointestinal and liver manifestations in patients with COVID-19
por: Lee, I-Cheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ori71ui7st278f53su4u24g644